The SRT-100™: Non-Invasive Squamous Cell Carcinoma Treatment
While Mohs surgery has proven to be an extremely effective method of treatment for non-melanoma skin cancers like squamous cell carcinoma and basal cell carcinoma, there are many significant downsides to this procedure from a patient’s perspective. Depending on the operation, Mohs surgery can result in large, nasty scarring that requires reconstructive surgery by a […]
The Symptoms of Squamous Cell Carcinoma
The symptoms of squamous cell carcinoma often appear as scaly, irritated skin, or elevated growths similar to warts. Only a trained physician or specialist can decide for sure if it is squamous cell carcinoma. If you believe you may have a squamous cell carcinoma, see a doctor right away. In general, any change in preexisting […]
My New Favorite Thing: SUPERFICIAL RADIATION THERAPY
With Sensus’ superficial radiation therapy (SRT), we may be entering uncharted waters where keloid recurrence after surgery and SRT leads to no, or a very low, incidence of keloid recurrence. With this, we will change the paradigm in the treatment of keloids. The Sensus SRT-100 is a superficial radiation device that has FDA clearance—the first […]
3rd Annual American Cutaneous Oncology Society: SRT Best Practices Conference 2017 Recap Video
The SRT-100™: Non-Invasive Basal Cell Carcinoma Treatment
While Mohs surgery has proven to be extremely effective at treating non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, there are huge drawbacks to the procedure from the perspective of the patient. Depending on the operation, Mohs surgery can leave behind large, nasty scarring that requires reconstructive surgery by a plastic surgeon. […]
Sensus to Present at the 2017 Marcum MicroCap Conference
BOCA RATON, Fla., June 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe Sardano, the Company’s Chief Executive Officer, will present a corporate overview to investors at the 2017 Marcum MicroCap Conference on Thursday, […]
